Health technology company Color said on Tuesday it raised $100 million investment.
Color’s latest funding round was led by venture capital fund Kindred Ventures and funds and accounts advised by T Rowe Price Associates. Existing investors General Catalyst, Viking Global Investors and billionaire philanthropist Laurene Powell Jobs’ Emerson Collective also participated in the round.
Color has raised $378 million to date.
Color plans to widen access to screening, diagnostics and initial treatments. It has more than 6,500 COVID-19 testing and 500 vaccination sites in the United States.
Besides COVID-19 testing, the California-based company also conducts genetic testing.
Color has tied up with nearly 1,000 organizations, including public health departments, universities and employers. It has also partnered with Thermo Fisher Scientific, Salesforce.com and the State of California, among others.
